Validation of EGFL6 expression as a prognostic marker in patients with lung adenocarcinoma in Taiwan: a retrospective study

OBJECTIVE: Lung adenocarcinoma is a non-small cell lung cancer, a common cancer in both genders, and has poor clinical outcome. Our aim was to evaluate the role of epidermal growth factor (EGF)-like domain multiple 6 (EGFL6) and its prognostic significance in lung adenocarcinoma. METHODS: EGFL6 expr...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Chun-Chi, Sung, Wen-Wei, Hsu, Hui-Ting, Yeh, Chung-Min, Lee, Chien-Hsun, Chen, Ya-Ling, Liu, Ta-Chih, Yeh, Kun-Tu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Pathology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6020984/
https://www.ncbi.nlm.nih.gov/pubmed/29934389
http://dx.doi.org/10.1136/bmjopen-2017-021385

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6020984/
https://www.ncbi.nlm.nih.gov/pubmed/29934389
http://dx.doi.org/10.1136/bmjopen-2017-021385

Ejemplares similares